Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2026-01-27 @ 2:13 PM
Study NCT ID:
NCT01758393
Status:
UNKNOWN
Last Update Posted:
2013-01-01
First Post:
2012-12-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Glucocorticoids in Patients With IgG4-RD
Sponsor:
Peking Union Medical College Hospital
Organization:
Study Overview
Official Title:
A Randomized Trial of Glucocorticoids in Patients With IgG4-Related Disease
Status:
UNKNOWN
Status Verified Date:
2012-12
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized, open-label, single-center clinical trial to compare the efficacy and safety profile for medium-dose versus high dose glucocorticoid in patients with IgG4-related Disease. Patients will be followed for three months to measure the primary outcome and secondary outcomes.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: